Vyndaqel 61 mg soft capsules
MGNT2022
Approved small_molecule active
Quick answer
Vyndaqel 61 mg soft capsules for Transthyretin cardiac amyloidosis is a Approved program (small_molecule) at Monte Rosa Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Monte Rosa Therapeutics
- Indication
- Transthyretin cardiac amyloidosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active